Agilent has announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the US Food and Drug Administration.
Agilent has announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the US Food and Drug Administration. Both instruments are manufactured at medical device establishments with the FDA, which is a requirement for manufacturing medical devices.
Gustavo Salem, vice president and general manager, Biological Systems Division, said, “The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community. We’re being very methodical in bringing this technology to the clinic, while ensuring that the equipment meets the laboratories’ needs.”
For more information please visit ref="http://www.agilent.com">www.agilent.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.